Percy William Cecil Lomax

Alexander David Investments Plc operates as an investment company. Its investment targets are small cap and special opportunities with a current bias towards basic resources and oil and gas sectors. The company was founded on February 11, 1998 and is headquartered in London, the United Kingdom.

ReGen Therapeutics Plc develops healthcare nutraceutical and ethical pharmaceuticals. Its principal activity is research and development of a drug product called Colostrinin for the treatment for Alzheimer's disease and other neurological disorders. It also involves in the development of Colostrinin peptides as pharmaceutical drug candidates for the treatment of Alzheimer's disease and obesity. ReGen Therapeutics Plc conducts pharmacokinetic and pharmacodynamic research. The company was founded on February 11, 1998 and is headquartered in London, the United Kingdom.

Part of Vaneltix Pharma, Inc., PolyMASC Pharmaceuticals Plc is a British company that researches and develops protein and peptide pharmaceuticals. The company is based in London, UK. The company was founded by Percy William Cecil Lomax. PolyMASC Pharmaceuticals was acquired by Valentis, Inc. on August 11, 1999 for $21.15 million.